Citation
(2011), "Benefit of adjuvant chemotherapy for resectable gastric cancer", Clinical Governance: An International Journal, Vol. 16 No. 2. https://doi.org/10.1108/cgij.2011.24816bae.011
Publisher
:Emerald Group Publishing Limited
Copyright © 2011, Emerald Group Publishing Limited
Benefit of adjuvant chemotherapy for resectable gastric cancer
Article Type: Reviews of effectiveness From: Clinical Governance: An International Journal, Volume 16, Issue 2
The Gastric (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group,Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis,JAMA,2010,Vol. 303,pp. 1729-1737
The authors concluded that there was a modest increase in survival over five years in patients with gastric cancer for adjuvant fluorouracil chemotherapy compared with surgery alone. This conclusion reflected the evidence presented and is likely to be reliable. However, the other eligible chemotherapy regimens were indistinguishable from fluorouracil.